Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Werner

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
New developments in cytomegalovirus prevention and managementD R Snydman, R H Rubin, B G Werner
The American Journal of Medicine|October 1, 1986
Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccineL M Kunches, D E Craven, B G Werner
International Journal of Cancer|December 15, 1980
Association of hepatitis B virus infection with hepatocellular carcinoma in American patientsR L Yarrish, B G Werner, B S Blumberg
Journal of Virology|October 1, 1979
Serological relationship of woodchuck hepatitis virus to human hepatitis B virusB G Werner, J M Smolec, R Snyder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, J Griffith, et al.
Lancet (London, England)|March 27, 1976
Anti-e in primary hepatic carcinomaB G Werner, B L Murphy, J E Maynard, et al.
The American Journal of Medicine|August 1, 1983
Hepatitis B exposure in emergency medical personnel. Prevalence of serologic markers and need for immunizationL M Kunches, D E Craven, B G Werner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study GroupM E Falagas, D R Snydman, R Ruthazer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1996
Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, R Ruthazer, et al.
Annals of Internal Medicine|February 15, 1997
Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, J Griffith, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
New developments in cytomegalovirus prevention and managementD R Snydman, R H Rubin, B G Werner
The American Journal of Medicine|October 1, 1986
Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccineL M Kunches, D E Craven, B G Werner
International Journal of Cancer|December 15, 1980
Association of hepatitis B virus infection with hepatocellular carcinoma in American patientsR L Yarrish, B G Werner, B S Blumberg
Journal of Virology|October 1, 1979
Serological relationship of woodchuck hepatitis virus to human hepatitis B virusB G Werner, J M Smolec, R Snyder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, J Griffith, et al.
Lancet (London, England)|March 27, 1976
Anti-e in primary hepatic carcinomaB G Werner, B L Murphy, J E Maynard, et al.
The American Journal of Medicine|August 1, 1983
Hepatitis B exposure in emergency medical personnel. Prevalence of serologic markers and need for immunizationL M Kunches, D E Craven, B G Werner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study GroupM E Falagas, D R Snydman, R Ruthazer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1996
Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, R Ruthazer, et al.
Annals of Internal Medicine|February 15, 1997
Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, J Griffith, et al.
Pageof 6